Search results

450 results

Sorted by Relevance . Sort by Date

  1. Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (HST3)

    Evidence-based recommendations on ataluren (Translarna) for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene in people aged

  2. Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)

    Evidence-based recommendations on burosumab (Crysvita) for treating X-linked hypophosphataemia (XLH) in children and young people

  3. Asfotase alfa for treating paediatric-onset hypophosphatasia (HST6)

    Evidence-based recommendations on asfotase alfa (Strensiq) for treating paediatric-onset hypophosphatasia in adults and children

  4. Cerliponase alfa for treating neuronal ceroid lipofuscinosis type 2 (HST12)

    Evidence-based recommendations on cerliponase alfa (Brineura) for treating neuronal ceroid lipofuscinosis type 2 in children

  5. Acne Vulgaris: Management

    In development [GID-NG10109] Expected publication date: 25 June 2021

  6. Shared decision making

    In development [GID-NG10120] Expected publication date: 17 June 2021

  7. SACT

    In development [GID-NG10184] Expected publication date: TBC

  8. Diabetes update

    In development [GID-NG10152] Expected publication date: TBC

  9. Weight Management

    In development [GID-NG10182] Expected publication date: 22 June 2023

  10. Pernicious anaemia

    In development [GID-NG10176] Expected publication date: 01 November 2023

  11. Mental wellbeing at work

    In development [GID-NG10140] Expected publication date: 02 March 2022

  12. Antenatal care

    In development [GID-NG10096] Expected publication date: 19 August 2021

  13. Inducing labour (update)

    In development [GID-NG10082] Expected publication date: 14 October 2021